DK1257278T3 - Anvendelse af mirtazapin til behandling af sövnforstyrrelser - Google Patents

Anvendelse af mirtazapin til behandling af sövnforstyrrelser

Info

Publication number
DK1257278T3
DK1257278T3 DK01902410T DK01902410T DK1257278T3 DK 1257278 T3 DK1257278 T3 DK 1257278T3 DK 01902410 T DK01902410 T DK 01902410T DK 01902410 T DK01902410 T DK 01902410T DK 1257278 T3 DK1257278 T3 DK 1257278T3
Authority
DK
Denmark
Prior art keywords
mirtazapine
treatment
sleep disorders
sleep
disorders
Prior art date
Application number
DK01902410T
Other languages
Danish (da)
English (en)
Inventor
Gerardus Stephanus Franc Ruigt
Den Berg Frans Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1257278T3 publication Critical patent/DK1257278T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK01902410T 2000-02-11 2001-02-06 Anvendelse af mirtazapin til behandling af sövnforstyrrelser DK1257278T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00200499 2000-02-11

Publications (1)

Publication Number Publication Date
DK1257278T3 true DK1257278T3 (da) 2006-06-12

Family

ID=8171013

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01902410T DK1257278T3 (da) 2000-02-11 2001-02-06 Anvendelse af mirtazapin til behandling af sövnforstyrrelser

Country Status (25)

Country Link
US (1) US6933293B2 (no)
EP (4) EP1656937A1 (no)
JP (1) JP5039994B2 (no)
KR (1) KR20020069371A (no)
CN (2) CN101229170A (no)
AR (1) AR027394A1 (no)
AT (1) ATE317261T1 (no)
AU (1) AU780439B2 (no)
BR (1) BR0108261A (no)
CA (1) CA2396209C (no)
CO (1) CO5271706A1 (no)
CZ (1) CZ302368B6 (no)
DE (1) DE60117122T2 (no)
DK (1) DK1257278T3 (no)
ES (1) ES2258071T3 (no)
HK (1) HK1049122B (no)
HU (1) HUP0204391A3 (no)
IL (2) IL150290A0 (no)
NO (1) NO328007B1 (no)
PE (1) PE20011080A1 (no)
PL (1) PL206073B1 (no)
RU (1) RU2270680C2 (no)
SK (1) SK287396B6 (no)
WO (1) WO2001058453A1 (no)
ZA (1) ZA200205238B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152055A1 (en) * 2003-01-30 2004-08-05 Gliessner Michael J.G. Video based language learning system
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
WO2005051349A2 (en) * 2003-11-25 2005-06-09 Aurobindo Pharma Ltd. Pharmaceutical compositions of mirtazapine
GB0417558D0 (en) * 2004-08-06 2004-09-08 Merck Sharp & Dohme Novel combination therapy
EP1806133A1 (en) * 2004-10-14 2007-07-11 Daikin Industries, Ltd. Method for modifying the ambience, and spray liquid and sprayer used in the method
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
JP2007284363A (ja) * 2006-04-13 2007-11-01 Daikin Ind Ltd 噴霧剤
CN101679431B (zh) 2007-04-11 2013-08-14 Msd欧斯股份有限公司 制备四环苯并氮杂卓的对映异构体的方法
US10603272B2 (en) 2015-02-27 2020-03-31 Kindred Biosciences, Inc. Stimulation of appetite and treatment of anorexia in dogs and cats
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
WO1999025356A1 (en) * 1997-11-14 1999-05-27 Akzo Nobel N.V. Use of mirtazapine for treating sleep apneas

Also Published As

Publication number Publication date
CZ20022330A3 (cs) 2002-11-13
KR20020069371A (ko) 2002-08-30
NO20023803D0 (no) 2002-08-09
HK1049122A1 (en) 2003-05-02
RU2270680C2 (ru) 2006-02-27
CZ302368B6 (cs) 2011-04-13
NO328007B1 (no) 2009-11-09
WO2001058453A1 (en) 2001-08-16
JP2003522147A (ja) 2003-07-22
CN101229170A (zh) 2008-07-30
PL206073B1 (pl) 2010-06-30
AR027394A1 (es) 2003-03-26
AU780439B2 (en) 2005-03-24
EP1658850A1 (en) 2006-05-24
CN1395487A (zh) 2003-02-05
PL356721A1 (en) 2004-06-28
JP5039994B2 (ja) 2012-10-03
DE60117122D1 (de) 2006-04-20
EP1257278A1 (en) 2002-11-20
IL150290A (en) 2010-12-30
PE20011080A1 (es) 2001-10-18
ZA200205238B (en) 2003-09-29
EP2283840A1 (en) 2011-02-16
BR0108261A (pt) 2003-03-05
RU2002124141A (ru) 2004-03-10
EP1656937A1 (en) 2006-05-17
AU3024701A (en) 2001-08-20
ES2258071T3 (es) 2006-08-16
CO5271706A1 (es) 2003-04-30
HK1049122B (zh) 2006-04-21
EP1257278B1 (en) 2006-02-08
NO20023803L (no) 2002-10-09
SK11442002A3 (sk) 2003-02-04
ATE317261T1 (de) 2006-02-15
IL150290A0 (en) 2002-12-01
US6933293B2 (en) 2005-08-23
HUP0204391A3 (en) 2005-03-29
SK287396B6 (sk) 2010-08-09
HUP0204391A2 (en) 2003-05-28
DE60117122T2 (de) 2006-07-27
CA2396209C (en) 2009-09-01
US20030022888A1 (en) 2003-01-30
CA2396209A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
DK1474416T3 (da) Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
NO20040097L (no) Kombinasjoner for behandling av inflammatoriske forstyrrelser
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DK1339406T3 (da) Piperazinderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af lidelser i centralnervesystemet
DK1231920T3 (da) Anvendelse af epinastin til behandling af allergisk rhinitis/conjunctivitis
DK1491212T3 (da) Middel til behandling af søvnforstyrrelser
DK1200081T3 (da) Anvendelse af escitalopram til behandling af generaliseret angstlidelse
DK1344526T3 (da) Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser
DK1345598T3 (da) Anvendelsen af rosiglitazon til behandling af psykiatriske lidelser
DK1257278T3 (da) Anvendelse af mirtazapin til behandling af sövnforstyrrelser
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
NO20032156L (no) Behandling av angstforstyrrelser
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
DK1468686T3 (da) S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser
FR2805983B3 (fr) Douche
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme